Rising Therapeutic Applications Drives the Global Specialty Enzymes Market, According to a New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Specialty Enzymes markets. Global market for Specialty Enzymes is forecast to reach US$4.7 billion by 2018, driven by rising therapeutic applications, advancements in enzyme engineering, and growing use as biocatalysts in drug manufacturing.

Specialty Enzymes: A Global Strategic Business Report

Follow us on LinkedIn – Enzymes, the natural protein molecules present in living organisms, function as specialized catalysts that speed up chemical reactions within a cell. Global demand for specialty enzymes including pharmaceutical enzymes, biocatalysts enzymes, diagnostic enzymes, and enzymes used in research and biotechnology, is expected to witness robust gains over the next few years. Usage in the pharmaceutical industry, whether for drug manufacture, disease diagnostics, or as therapy represents the most important end-use application of specialty enzymes. As pharmaceutical companies step up the use of biotechnology to introduce new drugs in the market, specialty enzymes such as polymerases and nucleases are expected to witness significant growth. Enzyme demand in the research and biotechnology end-market would also benefit from the drop in DNA sequencing costs and the development of new sequencing techniques. The number of investigations, as a result, is expected to increase creating a strong business case for specialty enzymes.

Therapeutic applications where enzymes are required in very small amounts but in high degree of specificity and purity, are expected to drive future growth in the market. Growing significance of enzymes in therapies for diseases such as cancer, lysosomal storage disorders, pain and inflammation management, cardiovascular diseases, among others, is a tidal force fuelling market demand. For instance, speciality enzymes are used to prevent dangerous blood clots in the treatment of haemophilia; as a digestion aid by supplementing the natural amylase, lipase and protease produced by pancreas; and as lactase supplements in people with lactose intolerance.

Advancements in enzyme technology such as immobilization of enzymes are further expected to widen the scope of applications in the fields of biotechnology, biomedical and pharmaceuticals thus strengthening market prospects. Aging population, especially in the developed countries, and the rising awareness about the nutritional benefits of enzyme supplementation represents a boon for the therapeutic and diagnostic enzymes market.

Specialty Enzymes as biocatalysts in the manufacture of drugs and fine chemicals offers significant growth opportunities. Usage of enzymes in the manufacturing process leads to less wastage as enzymes are biodegradable. In addition, the stereo-chemical and chemical selectivity offered by enzymes makes them ideal alternatives to several conventional chemical catalysts used in drug and fine chemical production.

As stated by the new market research report on Specialty Enzymes, the United States represents the largest market worldwide. Rising elderly population and the corresponding increase in demand for advanced therapeutic as well as diagnostic enzymes along with the need for cost-efficient drug manufacturing processes are all key factors propelling demand for specialty enzymes in the country. Asia Pacific is forecast to register a CAGR of 12% over the analysis period representing the fastest-growing market worldwide. Driven by environmental concerns and technological advances, the market for specialty enzymes continues to register impressive growth in the region. Robust growth is projected for enzymes used in the research and biotechnology sector in China and India.

Major market participants covered in the report include Advanced Enzyme Technologies Ltd., Advanced Vital Enzymes Ltd., Amano Enzyme Inc., AST Enzymes, Biocatalysts Ltd., BBI Solutions, Chr. Hansen Holding AS, Codexis Inc., Genzyme Corporation, Life Technologies Corporation, Meteoric Life Sciences, National Enzyme Company, ROCHE Holding Inc., and Specialty Enzymes & Biotechnologies Co., among others.

The research report titled “Specialty Enzymes: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, growth drivers challenges, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections for Specialty Enzymes in US$ for major product categories including Proteases, Polymerases, Carbohydrates, and Others. Geographic markets analyzed in the report include the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, South Korea and Rest of Asia-Pacific), Latin America (Brazil, and Rest of Latin America), and Rest of World. Key end-use applications analyzed in the report include Pharmaceuticals & Diagnostics; Research/Biotechnology; and Others.

For more details about this comprehensive market research report, please visit –

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website